Factor XI inhibitors: A new era in antithrombotic therapy

Introduction

Oral anticoagulants represent an effective alternative in the prophylaxis and treatment of venous and arterial thrombosis. Direct-acting oral anticoagulants (DOACs) have replaced anti-vitamin K agents, such as Sintrom® and warfarin, in numerous indications, as they are at least as effective in preventing stroke in patients with non-valvular atrial fibrillation (NVAF) and in the treatment of venous thromboembolism (VTE), but are associated with a lower incidence of...

CITATION  Med Clin (Barc). 2023 Oct 18:S0025-7753(23)00551-1.  doi: 10.1016/j.medcli.2023.09.003